A portable MICRO-GC medical device used by physicians to detect various biomarkers indicating various illnesses such as COVID-19, colorectal cancer, and lung cancer.
The device separates >100 volatile chemical compounds in a breath in 10 minutes with a sub-ppb (parts-per-billion), thanks to the micro-scale components such as the microfluidic detector.
Device readings are encrypted and sent to our cloud platform where they are analyzed using our proprietary algorithm which has been developed based on machine learning and artificial intelligence to analyze breath patterns revealing diseases and human health conditions. Results are finally relayed back to the device.
Only Micro-GC marketed directly to Physician Offices, Hospitals, Dentist and Veterinarians. The customer will be able to offer a low cost, non-invasive, early detection screening for multiple maladies, without a lab, in minutes
Micro GC device can be used in hospitals and at the point-of-care (POC) to provide timely information about disease and health conditions. It can be placed at bedside to analyze breath every 30 minutes, just like an electrocardiogram (ECG) that analyze the heart condition every second.
Specificity | Sensitivity | Predictive Value | |
---|---|---|---|
LUNG CANCER | 96% | 88% | 95.7% |
COLORECTAL CANCER | 100% | 94.3% | 96.2% |
COVID-19 | 96.7% | 93.3% | 95% |
Given time and resources, we can test for an endless list of diseases and pathogens